Vaccines for Immune Mediated Diseases

Patients with immune-mediated inflammatory diseases (IMID) such as RA, IBD or psoriasis, are at increased risk of infection, partially because of the disease itself, but mostly because of treatment with immune-modulatory or immunosuppressive drugs. In spite of their elevated risk for vaccine-preventable disease, vaccination coverage in IMID patients is surprisingly low. Although the reduced quality of the immune response in patients under immunotherapy may have a negative impact on vaccination efficacy in this population, adequate humoral response to vaccination in IMID patients has been demonstrated for Hepatitis B, Influenza and Pneumococcal vaccination. 

  • Innate immunity and diabetes vaccines
  • Central nervous system-targeted & Tissue-specific autoimmunity
  • Vaccines for immunodeficiency diseases
  • Vaccines for autoimmune skin disorders & neuropathies
  • Vaccination strategy in patients with IMID
  • Vaccine safety: impact on disease activity in IMID patients
  • Vaccine safety: impact on disease activity in IMID patients

Related Conference of Vaccines for Immune Mediated Diseases

September 18-19, 2017

20th Global Summit & Expo on Vaccines, Immunization & B2B

(Global B2B Meetings in 1 Event) Houston, Texas USA
October 30-31, 2017

19th International Vaccines & B2B Congress

Chicago, USA
August 09-10, 2018

27th Euro Congress on Cancer Science & Therapy

Madrid, Spain

Vaccines for Immune Mediated Diseases Conference Speakers

Recommended Sessions

Related Journals

Are you interested in